Journals / Erciyes Tıp Dergisi / 2008 / Cilt: 30 - Sayı: 1

Paklitaksel ve sisplatinin ratlarda over rezervi üzerine olan etkileri

Effects of paclitaxel and cisplatin on ovarian reserves in rats

Pages
24–29
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hematoxylin-eosin stain was used to determine the follicles.Results: Number of primordial, primary, and secondary follicles were found to show a statistically significant decrease (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: We targeted to investigate the effects of paclitaxel and cisplatin treatments, both solely and in combination with each other, on ovarian reserves in rats.
📊
Key Findings & Data:Materials and methods: Forty female Wistar albino rats were divided into 4 groups as to include 10 rats in each.
💡
Conclusion & Impact:Hematoxylin-eosin stain was used to determine the follicles.Results: Number of primordial, primary, and secondary follicles were found to show a statistically significant decrease (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: We targeted to investigate the effects of paclitaxel and cisplatin treatments, both solely and in combination with each other, on ovarian reserves in rats. Materials and methods: Forty female Wistar albino rats were divided into 4 groups as to include 10 rats in each. While 7.5 mg/kg paclitaxel was given to group II, 5mg/kg cisplatin was administered to group III, 7.5 mg/kg paclitaxel and 5 mg/kg cisplatin combination therapy was applied to group IV via intraperitoneal route in a sterile way at single dose. Group I, which was assigned to be the control group, was subjected to intraperitoneal sterile saline in equal volumes. One week after the chemotherapy, ovaries of all the rats were oophorectomized. Hematoxylin-eosin stain was used to determine the follicles.Results: Number of primordial, primary, and secondary follicles were found to show a statistically significant decrease (p

Özet

Amaç: Paklitaksel ve sisplatinin tek başına ve kombine olarak uygulanmasının ratlarda over reservi üzerine olan etkilerini araştırmak amaçlandı. Gereç ve Yöntemler: Wistar albino cinsi 40 adet dişi rat her grup 10 rat içerecek şekilde 4 gruba ayrıldı. Grup 2'ye 7.5 mg/kg paklitaksel, grup 3'e 5mg/kg sisplatin, grup 4 ise 7.5 mg/kg paklitaksel ve 5 mg/kg sisplatin kombine olarak steril şekilde intraperitoneal tek doz olarak uygulandı. Kontrol grubu olan grup 1'e ise eşit volümde steril serum fizyolojik intraperitoneal olarak uygulandı. Kemoterapiden 1 hafta sonra tüm ratlar ooferektomize edilerek overleri çıkarıldı. Hematoksilen ve eozin boyası follikülleri tespit etmek için kullanıldı.Bulgular: Kontrol grubuna göre tedavi alan gruplarda primordial, primer, sekonder follikül sayılarında istatistiksel olarak anlamlı derecede azalma tespit edildi. (p

🔖

Cite This Article

ATAKUL, T., BATUKAN, C., ÖZÇELİK, B., SERİN, İ. S., TÜRKYILMAZ, Ç., ÖZGÜN, M. T., ÖZDAMAR, S. (2022). Paklitaksel ve sisplatinin ratlarda over rezervi üzerine olan etkileri. Erciyes Tıp Dergisi, Cilt: 30 - Sayı: 1, 24–29. https://ajindex.com/articles/502649

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Meirow D, Lewis H, Nugent D, Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 1999;14:1903–1907. 2.Byrne J, Fears TR, Gail MH et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992;166:788–793. 3.Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001;7:535–543. 4.Smith BJ, Plowchalk DR, Sipes IG, Mattison DR. Comparison of random and serial sections in assessment of ovarian toxicity. Reprod Toxicol 1991;5:379–383. 5.Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14:1718–1729. 6.Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999;17:2365–2370. 7.Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10:251–266. 8.Wang TH, Wang HS, Soong YK. Paclitaxel-induced cell death. Where the cell cycle and apoptosis come together. Cancer 2000;88:2619 –2628. 9.Mailhes JB, Carabatsos MJ, Young D, London SN, Bell M, Albertini DF. Taxol-induced meiotic maturation delay, spindle defects, and aneuploidy in mouse oocytes and zygotes. Mutat Res 1999; 423:79 –90. 10.Himelstein-Braw R, Byskov AG, Peters H, Faber M. Follicular atresia in the infant human ovary. J Reprod Fertil 1976;46:55-59. 11. Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR and Motta PM. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod 1993;10:2080–2087. 12.Gerschenson M, Paik CY. Cisplatin exposure induces mitochondrial toxicity in pregnant rats and their fetuses. Reprod Toxicol. 2001;15:525–531 13. Nelson Gustavo Neder Kalil and William Patrick McGuire. Chemotherapy for advanced epithelial ovarian carcinoma.ÊBest Practice & Research Clinical Obstetrics & Gynaecology 2002:16:553-557 14.Yucebilgin MS, Terek MC, Ozsaran A, Akercan F, Zekioglu O, Isik E, Erhan Y. Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility. Aust N Z J Obstet Gynaecol. 2004;44:6-9 15.Letterie GS. Anovulation in the prevention of cytotoxic-induced follicular attrition and ovarian failure. Human Reproduction. 2004;19:831-837